Myocardial infarction and post-myocardial management: Yesterday through the scope of traditional healthcare and tomorrow the view of preventive and personalized medicine
autologous cell can be applied without immunosuppression, and the cells have been exposed to risk factors and aging. Allogeneic cell therapy enables preoperative production of po-tent cell lines ... theshelf therapy…

